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ThephospholipaseA2 (PLA2) enzymes are activatedbybinding to
phospholipid membranes. Although the N-terminal -helix of
group I/II PLA2s plays an important role in the productive mode
membrane binding of the enzymes, its role in the structural aspects
of membrane-induced activation of PLA2s is not well understood.
In order to elucidate membrane-induced conformational changes
in the N-terminal helix and in the rest of the PLA2, we have created
semisynthetic human group IB PLA2 in which the N-terminal
decapeptide is joined with the 13C-labeled fragment, as well as a
chimeric protein containing the N-terminal decapeptide from
human group IIA PLA2 joinedwith a 13C-labeled fragment of group
IB PLA2. Infrared spectral resolution of the unlabeled and 13C-la-
beled segments suggests that the N-terminal helix of membrane-
bound IBPLA2 has amore rigid structure than the other helices. On
the other hand, the overall structure of the chimeric PLA2 is more
rigid than that of the IB PLA2, but the N-terminal helix is more
flexible. A combination of homology modeling and polarized infra-
red spectroscopy provides the structure of membrane-bound chi-
meric PLA2,which demonstrates remarkable similarity but also dis-
tinct differences compared with that of IB PLA2. Correlation is
delineated between structural andmembrane binding properties of
PLA2s and their N-terminal helices. Altogether, the data provide
evidence that the N-terminal helix of group I/II PLA2s acts as a
regulatory domain that mediates interfacial activation of these
enzymes.
Enzymes of the phospholipase A2 (PLA2)2 family hydrolyze the sn-2
ester bond of diacylglycerophospholipids and thus initiate the biosyn-
thesis of lipid-derived mediators, such as eicosanoids and platelet-acti-
vating factor, which are potent mediators of inflammation, allergy, and
tumorigenesis (1–3). These enzymes are divided into several groups and
subgroups based on their amino acid sequences, tissue distribution, and
functional features (1, 2).
PLA2s gain their full activity only when they bind to phospholipid
micelles or membranes, an effect known as interfacial activation (4–6).
The molecular mechanism of interfacial activation has been the subject
of debate over several decades. Initially, similarities of crystal structures
of PLA2s with and without bound substrate mimics argued against con-
formational changes in the enzymes during interfacial activation (4).
Later, the interfacially activated form of group IB PLA2 was modeled by
anion-mediated dimers (7), which revealed significant conformational
changes compared with “inactive” monomeric forms, mainly involving
the loop that has the functionally important Tyr69, and the presence of
an assisting water molecule (8). Several spectroscopic studies also iden-
tified conformational changes in group IB and IIA PLA2s upon binding
to phospholipidmicelles or membranes. Fluorescence studies indicated
that the N-terminal helix of porcine group IB PLA2 becomes rigid upon
enzyme-substrate complex formation at the membrane surface (9, 10).
This was confirmed by NMR experiments, which indicated that the
N-terminal -helix and H-bonded catalytically important residues of
porcine group IB PLA2 were flexible in the aqueous buffer and adopted
a fixed conformation in a ternary complex of the enzyme with a sub-
strate analog and phospholipid micelles (11, 12). Stabilization of the
structure of membrane-bound human group IB was identified by Fou-
rier transform infrared (FTIR) spectroscopy (13). In contrast, NMR and
FTIR data have indicated that group IIA PLA2s are characterized with
stable secondary structure free in solution, including the N-terminal
helix, and membrane binding of these enzymes is accompanied with
destabilization of -helices (14–17).
Previously, we have shown that deletion of the N-terminal -helix of
human IB PLA2 results in a loss of the productive mode membrane
binding capability and a 100-fold inhibition of the enzyme activity (13).
Thus, experimental evidence accumulated to date suggests that the
N-terminal -helix of group I/II PLA2s is a crucial structural domain
necessary for a productive mode membrane binding and activity of the
enzymes (13), conformational changes do occur in these enzymes dur-
ing interfacial activation involving the N-terminal helix, and these con-
formational changes are group-specific. In order to understand the sig-
nificance of differences in membrane-induced conformational changes
in group I and II PLA2s and the role of the N-terminal helix, it is impor-
tant to examine the structural and functional effects of replacement of
the N-terminal helix between PLA2 isoforms. In this work, we present
our findings on the effects of substitution of the N-terminal helix of
human group IB PLA2 (hIBPLA2) by that of human group IIA PLA2
(hIIAPLA2) on the enzyme activity, membrane binding strength, mem-
brane-induced conformational changes, and the precise mode of mem-
brane binding. In order to monitor structural changes in individual
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helical segments of the protein, we have chemically ligated unlabeled
synthetic decapeptides corresponding to the N-terminal helix of either
IB or IIA PLA2s with the uniformly 13C-labeled fragment of hIBPLA2
that lacks the first 10 residues, and we used the semisynthetic, segmen-
tally 13C-labeled proteins to assess site-specific conformational effects
upon membrane binding. Segmental isotope labeling also allowed
determination of the angular orientation of membrane-bound proteins
by polarized attenuated total reflection Fourier transform infrared
(ATR-FTIR) spectroscopy. Observed conformational differences in the
N-terminal and internal helices of hIBPLA2 and of the chimeric PLA2
(N10IIA/IB) containing the first 10 residues of hIIAPLA2 and the rest
from hIBPLA2 indicate an important role for the N-terminal helix as a
domain that regulates structural transformations during interfacial acti-
vation and facilitates proper membrane binding of group I/II PLA2s.
EXPERIMENTAL PROCEDURES
Materials—The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phos-
phoglycerol (POPG) were purchased from Avanti Polar Lipids
(Alabaster, AL). N-(Fluorescein-5-thiocarbamoyl)-1,2-dihexade-
canoyl-sn-glycero-3-phosphoethanolamine (FPE) was from Invitro-
gen. The N-terminal decapeptides of hIBPLA2 and hIIAPLA2,
Ac-Ala-Val-Trp-Gln-Phe-Arg-Lys-Met-Ile-Lys-NH2 (N10hIB) and
Ac-Asn-Leu-Val-Asn-Phe-His-Arg-Met-Ile-Lys-NH2 (N10hIIA),
respectively, were synthesized by Advanced ChemTech (Louisville,
KY) and were 99% pure, as confirmed by high pressure liquid chro-
matography and mass spectrometry. C-terminally thioesterified
peptides, containing a –COSCH2COOH group at the C terminus,
were synthesized by SynPep Corp. (Dublin, CA) and were 99% pure.
Most of other chemicals were purchased from Sigma.
Production of Recombinant and Semisynthetic Proteins—The semi-
synthetic, segmentally 13C-labeled hIBPLA2 was produced as described
previously (18). Briefly, the plasmid for the PLA2 fragment N10 that
lacks the first 10 residues was constructed by using a human pancreatic
cDNA library, and the uniformly 13C-labeled N10 was expressed in
Escherichia coli BL21(DE3) in an M9 minimal medium using 13C6-D-
glucose as a single metabolic source of carbon. The N10 fragment was
purified by ion exchange and size exclusion columns, as described (18).
The C-terminally thioesterified N-terminal decapeptide N10hIB was
ligated with the N-terminal cysteine of the N10 fragment, followed by
refolding of the ligated PLA2 by dialysis against 25 mM Tris-HCl, 5 mM
CaCl2, 5mM L-cysteine, 0.9M guanidiniumHCl (pH8.0), and purified by
using an ion exchangeMonoQ5/50 column. The chimeric, segmentally
13C-labeled N10IIA/IB PLA2 was produced in a similar manner except
that the thioesterified N10hIIA peptide was used for chemical ligation.
In both cases, the ligation reaction was allowed to proceed for 6 h at
37 °C. The ligated protein was separated from the unligated peptide and
the N10 fragment by an ion exchangeMono Q column. The profile of
elution of the chimeric PLA2 sample from theMono Q column showed
two major protein peaks (Fig. 1A), one of which was identified as the
chimeric PLA2 and the other as the unligated N10 fragment (the pep-
tide was eluted before the ligated PLA2). Analysis of the elution peaks by
SDS-PAGE showed that the chimeric PLA2 was purified to homogene-
ity (Fig. 1B). The prokaryotic expression vector with the inserted
hIIAPLA2 gene that incorporates anN1Amutationwas kindly provided
by Prof. David Wilton (University of Southampton, UK). Expression
and purification of hIIAPLA2 were conducted as described (19), except
the purification by a heparin column was followed by additional purifi-
cation using a size exclusion HiLoad Superdex 75 column, which
yielded highly pure and active enzyme.
PLA2 Activity Assay—PLA2 activity was measured using an sPLA2
activity kit from Cayman Chemical (Ann Arbor, MI), as described (13).
The assay buffer contained 100 mM KCl, 10 mM CaCl2, 0.3 mM Triton
X-100, 1 mg/ml bovine serum albumin, 25 mM Tris-HCl (pH 7.5), 0.4
mM5,5-dithio-bis-(2-nitrobenzoic acid), and 1.5mMdiheptanoyl-thio-
phosphatidylcholine (DHTPC) as a PLA2 substrate. The sample was
contained in a 0.4-cm optical path length rectangular quartz cuvette.
The reaction was initiated by adding 3l of a 67g/ml PLA2 solution to
a final PLA2 concentration of 1.0 g/ml, and the enzyme activity was
monitored by an increase in absorption at 414 nm due to PLA2-cata-
lyzed cleavage of DHTPC, exposure of thiol groups, and monomeriza-
tion of 5,5-dithio-bis-(2-nitrobenzoic acid). A Cary 100 double-beam
spectrophotometer (Varian Inc., Palo Alto, CA) was used. The specific
activity (vo) of PLA2 was calculated based on the initial slope of the time
dependence of absorption at 414 nm, using an extinction coefficient of
414  13,600 M1 cm1 for 5-thionitrobenzoic acid.
Fluorescence and Circular Dichroism Experiments—Fluorescence
and CD measurements were conducted using a Jasco 810 spectroflu-
oropolarimeter (Jasco Corp., Tokyo, Japan), as described previously
(13). This particular model is designed for CD experiments and is
equipped with an additional photomultiplier tube mounted at 90o for
fluorescence measurements, as well as with a Peltier temperature con-
troller. Fluorescence experiments were carried out on samples in 100
mM NaCl, 1 mM NaN3, and 50 mM Hepes (pH 7.4) contained in a rec-
tangular 0.4-cm optical path length quartz cuvette, at 22 °C, using exci-
tation and emission slits of 4 and 10 nm, respectively. For CD experi-
ments, the proteins were dissolved in a 10mM sodiumphosphate buffer,
pH 7.4, andmeasurements were conducted using a 0.5-mmoptical path
length quartz cuvette. In both fluorescence and CD experiments, five
FIGURE 1. Purification of the semisynthetic, segmentally 13C-labeled chimeric PLA2
by ion exchange chromatography. The thioesterified decapeptide Asn-Leu-Val-Asn-
Phe-His-Arg-Met-Ile-Lys-NH2-COSCH2COOH was ligated with the
13C-labeled fragment
N10 in a buffer containing 6 M guanidinum-HCl, 100 mM sodium phosphate, 5% -mer-
captoethanol, 1 mM EDTA, 4% thiophenol, and 4% benzyl mercaptan, pH 7.4. The con-
centrations of the N10 fragment and the peptide were 16 and 1.6 mg/ml, respectively.
The reaction was allowed to proceed for 6 h at 37 °C, followed by refolding of the ligated
protein and purification using ion exchange Mono Q 5/50 column chromatography.
A, the elution profile of the sample from the Mono Q column (continuous line, left axis).
The initial buffer was 20 mM Tris-HCl (pH 9.0). Elution was conducted with a stepwise
increase of NaCl concentration in the same buffer (broken line, right axis), and 0.5-ml
fractions were collected. The peak at fraction number 25 was the ligated product, i.e. the
chimeric PLA2, as confirmed by its molecular mass, high PLA2 activity, and spectroscopic
data, whereas the peak at fraction number 32 was the unligated 13C-labeled N10 frag-
ment. The free peptide eluted before the chimeric PLA2. B, Coomassie-stained SDS gel of
elution fractions shown in A. The single band corresponding to fraction 25 shows that
the ligated chimeric PLA2 was isolated as a pure protein.
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scans were averaged, and the spectra were corrected by subtracting the
spectra of blank buffers.
Membrane Binding Experiments—In order tomeasure the binding to
phospholipid membranes of the N10IIA/IB chimeric PLA2, as well as of
group IB and IIA PLA2s and their N-terminal decapeptides, fluores-
cence spectroscopy was used. The conventional resonance energy
transfer technique could not be used because some molecules did not
have tryptophan (the N10IIA/IB and hIIAPLA2) and some did not have
any fluorophores at all (the N10hIIA peptide). Instead, the increase in
fluorescence emission intensity of FPE in vesicle membranes upon pro-
tein or peptide binding was used, as described before (20, 21). FPE was
incorporated at 2 mol % in large unilamellar phospholipid vesicles,
which were prepared by extrusion through 100-nm pore size polycar-
bonate membranes, as described (13). The buffer was 10 mM Hepes, 1
mM NaN3, 1 mM EGTA (pH 7.4), and fluorescence experiments were
conducted as described above. Excitation was at 490 nm, and emission
spectra were recorded between 502 and 540 nm at 22 °C. After record-
ing an initial spectrumof vesicles in the buffer, proteins or peptideswere
added to the lipid suspension at increasing concentrations from a stock
solution, and consecutive fluorescence emission spectra were recorded
following equilibration of the sample for 2 min, with constant stirring.
The fluorescence intensity of FPE is sensitive to the ionization state of
the carboxyl group of fluorescein; the emission intensity increases with
increasing deprotonation. The fluorescein moiety of FPE is located at
the interface of the negatively chargedmembrane, where the local envi-
ronment is more acidic than the bulk phase because of electrostatic
attraction of protons to the membrane. This causes partial protonation
of the carboxyl group of fluorescein, resulting in a moderate level of
fluorescence intensity. Adsorption of cationic protein or peptide mole-
cules to themembrane reduces the negative surface charge of themem-
brane, which results in a protein (or peptide) dose-dependent deproto-
nation of fluorescein and an increase in the fluorescence intensity. This
effect was used tomeasure binding isotherms for PLA2s and theirN-ter-
minal peptides.
Analysis of Membrane Binding Data—Binding of proteins and pep-
tides to membranes was analyzed using a logic described earlier (13).
The protein is added to preformed lipid vesicles, resulting in binding of
the protein to the external surface of vesicles. If one considers that only
a fraction  of the total lipid is accessible to the protein, and the binding
of each proteinmolecule makes N lipidmolecules inaccessible for other
proteins, then the dissociation constant of the binding process can be





where [P] and [L] are the total concentrations of the protein and the
lipid, respectively, and [P]b is the concentration of the membrane-
bound protein. When the lipid fluorescence is monitored as the lipid is
being titrated with the protein, the relative change in the fluorescence







where F is the change in fluorescence intensity at a given protein
concentration; Fmax is the saturating level of F at high protein con-
centration, and [L]b is the concentration of protein-bound lipid. We
have used F values at 518 nm. Using [P]b  [L]b/N  Frel[L]/N
(where Frel ' F/Fmax), we convert Equation 1 into a quadratic
equationwith respect toFrel and solve it as shown in Equations 3 and 4,




2 NKD  PL  1 (Eq. 4)
The plus sign in front of the square root is useless because it results in
values of Frel 	1. It is seen from Equation 1 that at half-saturation of
protein binding, when Frel  0.5 (Equation 5),




where [P]1⁄2 is the protein concentration corresponding to Frel  0.5.
Changes in FPE fluorescence intensity, F, were measured at various
protein concentrations, [P], and F values were plotted against F/[P].
These linear (Scatchard) plots were used to evaluate Fmax and [P]1⁄2
from the extrapolated intercept with the F axis and from the slope,
respectively. Experimental binding isotherms were constructed by plot-
ting F/Fmax against [P]. The theoretical isotherms were simulated
through Equation 3 using KD and N as fitting parameters. Despite two
fitting parameters, determination of both KD and N by this method is
reliable. In Equation 5, [P]1⁄2 can be determined using the experimental
data, as described above, and  is 0.52 for vesicles 100 nm in diameter,
with amembrane thickness of 4 nm (13). Replacement ofKD in Equation
4 by the expression in equation 5 yields an equation with only one
unknown, i.e. N. Hence, fitting of the experimental curves can be done
by varying N in a physically reasonable range, and once a best fit is
achieved, the KD value can be calculated through Equation 5 by using
the best fit value of N. The Gibbs free energies of membrane binding,
Gb, were calculated using dissociation constants, as described (13).
Attenuated Total Reflection FTIR Experiments—Polarized ATR-
FTIR experiments were carried out using a Vector 22 FTIR spectrome-
ter (BrukerOptics, Billerica,MA), as described previously (13). Amodel
611 Langmuir-Blodgett trough (Nima, Coventry, UK) was used to
deposit a POPC monolayer on a germanium internal reflection plate
0.1
 2
 5 cm3 in size andwith 45o angles (Spectral Systems, Irvington,
NY), followed by injection of sonicated vesicles composed of 80 mol %
POPC and 20 mol % POPG and formation of supported phospholipid
membranes. The protein or the peptide was dissolved in an H2O-based
buffer consisting of 100 mM NaCl, 1 mM NaN3, 1 mM EGTA, 50 mM
Hepes (pH 7.4) and was injected into the ATR cell that contained the
supported membrane. After allowing the protein to bind to the mem-
brane (15min), the cell was gently flushedwith a 2H2O-based buffer of
the same composition, followed by recording a series of spectra at alter-
nating parallel and perpendicular polarizations of the incident infrared
light, at 2 cm1 resolution. The polarized spectra were used for two
purposes. First, the spectra measured at parallel and perpendicular
polarization were used to create “corrected” spectra asAcorrected A 
0.8A, which were used for calculation of the second derivative spectra
and evaluation of secondary structures of proteins, as described before
(13, 22). Second, the polarized spectra were used to evaluate the linear
dichroic ratios andmolecular orientationwith respect to themembrane
normal, as described (13, 23). Simulation of second derivatives was
accompaniedwith 13-point Savitzky-Golay smoothing in order to avoid
amplification of high frequency noise. Amide I components were
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obtained by curve fitting, using the number and positions of the inverted
second derivative peaks as input parameters. The results of curve fitting
were considered satisfactory when the peak frequencies of all compo-
nents were within a 1 cm1 range compared with the input frequen-
cies andwhen the sumof all components (the “curve fit”) was practically
identical to the measured spectrum.
Determination of the Orientation of Membrane-bound PLA2—The
orientation of membrane-bound chimeric N10IIA/IB PLA2 was deter-
mined by polarized ATR-FTIR spectroscopy. First, the structure of the
proteinwasmodeled by Swiss-Model (24) using the structure of porcine
pancreatic PLA2 as a template (Protein Data Bank entry 1P2P). The
modeled structure had three -helices, which we call helix 1 (residues
1–10), 2 (residues 43–57), and 3 (91–108). The C- atom coordinates
were used to determine the orientations of all three -helices of the
protein relative to the “protein” coordinate systempwith axes x*, y*, z*,
in which the coordinates are given, and the helical orientations were
further used to determine all interhelical angles, using the analytical
geometry algorithms described earlier (18). This indicated that the angle
between the helices 2 and 3 was 6.2°, which allowed us to consider these
two helices approximately parallel to each other and to use a common
order parameter to describe their orientation with respect to the mem-
brane. (When the N 3 C directionality of helices is considered, the
interhelical angle would be 173.8o, but in terms of infrared order param-
eters, parallel and antiparallel helices are equivalent.) Polarized ATR-
FTIR spectroscopy was used to measure the amide I bands of the mem-
brane-bound, segmentally 13C-labeled chimeric N10IIA/IB PLA2 at
parallel and perpendicular orientations of the infrared light. Spectral
separation of the -helical signals generated by the unlabeled N-termi-
nal helix and the 13C-labeled helices 2 and 3 allowed determination of
two order parameters, one for the N-terminal helix and one for the
helices 2 and 3. Knowledge of the orientations of the two helices in the
protein coordinate systemp andwith respect to themembrane normal
then allowed determination of the angles between the membrane nor-
mal and the three axes of the system p, using an algorithm described
elsewhere (18). This provides the angular orientation of the protein
molecule relative to the membrane.
An ideal way to position precisely the protein at the membrane sur-
face is to determine the coordinates of the protein atoms in a “mem-
brane” coordinate system, m, with axes x, y, and z, which has its xy
plane in the membrane center, between the two lipid leaflets, and the z
axis is perpendicular to the membrane surface. This was achieved as
follows. The protein molecule was considered at an arbitrary rotation
about the z axis, maintaining the angles between the z axis and the three
axes of the protein system p, as determined above. This does not
reduce the generality because the protein has an unrestricted rotational
freedom about the z axis. This allows determination of all nine angles
between the protein and membrane coordinate systems, using the laws
of direction cosines, which in turn allows transformation of the protein
atom coordinates from the system p to the system m.
RESULTS AND DISCUSSION
Initial Structure-Function Characterization of the Chimeric
N10IIA/IB PLA2—The initial structure-activity characterization of the
chimeric N10IIA/IB PLA2 involved fluorescence and CD experiments
and an activity assay. The chimeric protein is devoid of tryptophans but
contains nine tyrosines, hence its fluorescence spectrum was measured
based on tyrosine emission. As shown in Fig. 2A, the protein had a
fluorescence emission maximum around 308 nm when excited at 275
nm, which is close to the tyrosine emission peak at 306 nm in folded
proteins (13, 25, 26). Because fluorescence spectra provide little infor-
mation on the secondary structure of proteins, we used CD spectros-
copy to evaluate the secondary structure content in the chimeric
N10IIA/IB PLA2 and to compare it with that of the group IB and IIA
PLA2s. The CD spectrum of the N10IIA/IB PLA2 demonstrated double
minima around 208 and 222 nm, with an absolute value of the mean
residuemolar ellipticity at 222 nm ([
]222) comparable with thosemeas-
ured for group IB and IIA PLA2s (Fig. 2B). This indicates that the chi-
meric protein is folded into a structure that comprises 40% -helix,
which is characteristic of group I/II PLA2s (4, 5). The shape of the CD
spectrum of the chimeric protein was different from those of the group
IB and IIA PLA2s, however. The CD spectrum of the N10IIA/IB PLA2
exhibited an increased ellipticity ratio [
]208/[
]222 as compared with
both hIBPLA2 and hIIAPLA2. Reduced values of the ellipticity ratio
[
]208/[
]222 are associated with deviations of the -helix structure from
a standard, rigid helix geometry, e.g. by formation of coiled-coil struc-
tures (27, 28) or distorted helices (29). Although two internal -helices
of group I/II PLA2s are nearly antiparallel and disulfide-bonded, they are
not likely to form a coiled-coil structure (see below). The observed
feature is thereforemore likely to indicate a less flexible conformation of
the chimeric PLA2 compared with the hIBPLA2 and hIIAPLA2.
To assess the influence of the substitution of the N-terminal helix on
PLA2 activity, the activity of the chimeric PLA2, as well as of hIBPLA2
FIGURE 2. Initial structure-function characterization of the chimeric N10IIA/IB PLA2. A, fluorescence spectrum of the semisynthetic chimeric PLA2 in a buffer containing 100 mM
NaCl, 1 mM NaN3, and 50 mM Hepes (pH 7.4), in a 0.4-cm optical path length quartz cuvette. Excitation was at 275 nm, and the emission peak was located at 308 nm, characteristic of
tyrosine fluorescence of a folded, tryptophan-less protein. B, circular dichroism spectra of the recombinant hIBPLA2 (dotted line), hIIAPLA2 (dashed line), and of the semisynthetic
chimeric PLA2 (continuous line) in a buffer containing 10 mM sodium phosphate buffer, pH 7.4, in a 0.5-mm optical path length quartz cuvette. All three proteins contain 40% -helix,
as judged from the ellipticity at 222 nm, but the shape of the spectrum of the chimeric protein suggests more rigid helices compared with those in hIBPLA2 and hIIAPLA2. C, activities
of the recombinant hIBPLA2 (dotted line), hIIAPLA2 (dashed line), and the semisynthetic chimeric PLA2 (continuous line) as measured in a buffer containing 100 mM KCl, 10 mM CaCl2,
0.3 mM Triton X-100, 1 mg/ml bovine serum albumin, 25 mM Tris-HCl (pH 7.5), 0.4 mM 5,5-dithio-bis-(2-nitrobenzoic acid), and 1.5 mM DHTPC as a substrate. PLA2s were added to a final
concentration of 1.0 g/ml, followed by stirring for 10 –15 s and recording the absorption at 414 nm. The method is based on PLA2-catalyzed cleavage of the sn-2 thioester bond
of DHTPC, exposure of free thiol groups that cause monomerization of 5,5-dithiobis(2-nitrobenzoic acid) resulting in characteristic absorption at 414 nm. The initial slopes of time
dependence of absorption were used to estimate activities of PLA2s. All measurements were conducted at 22 °C. See text for more details.
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and hIIAPLA2, was measured by using DHTPC micelles as substrate.
The activity of the chimeric enzyme, as evaluated based on the initial
slope of the time dependence of product accumulation, was vo  9  2
mol/min/mg (Fig. 2C), which is considerably lower than the activities
of hIBPLA2 and hIIAPLA2, 24  5 and 52  8 mol/min/mg, respec-
tively (shown are mean values and standard deviations from three
experiments). Although hIIAPLA2 shows little activity toward zwitteri-
onic phosphatidylcholine membranes (30, 31), it is more active than
hIBPLA2 toward micelles of short chain DHTPC. A possible explana-
tion of this is that the extremely high excess positive charge of hIIAPLA2
(15 excess cationic charges at pH 7.4, see TABLE ONE) prevents
binding to zwitterionic membranes because of strong positive surface
charge of membranes that rapidly builds up upon binding of a few PLA2
molecules. Micelles, on the other hand, can afford binding of only one
PLA2 molecule at a time because of their small size, which precludes
electrostatic repulsion effects. These data indicate that in addition to
structural differences that are reflected in CD spectra, the chimeric
enzyme has a specific activity severalfold lower compared with those of
group IB and IIA enzymes.
The Structure ofMembrane-boundChimeric PLA2 as Compared with
That of the hIBPLA2—As described in the Introduction in more detail,
group IB PLA2s have been shown to acquire amore rigid structure upon
binding to phospholipidmicelles ormembranes, involving primarily the
N-terminal -helix (9–13), whereas membrane binding of group IIA
PLA2s results in more flexible -helices (14–17). Because the N-termi-
nal -helix of group I/II PLA2s is a crucial structural component of the
membrane binding face of these enzymes, it is important to identify its
contribution to changes in the secondary or dynamic structure of PLA2s
during membrane binding. In order to test the hypothesis that the
N-terminal helix of membrane-bound hIBPLA2 is rigid, but its substi-
tution by the N-terminal helix from hIIAPLA2 may impart flexibility to
the enzyme, we studied the semisynthetic hIBPLA2 in which an unla-
beledN-terminal decapeptidewas ligatedwith the 13C-labeled fragment
N10, as well as a semisynthetic, segmentally 13C-labeled chimeric
N10IIA/IB PLA2, by ATR-FTIR spectroscopy. The amide I spectra of
segmentally 13C-labeled proteins are broader and more complex than
those of unlabeled proteins. Amide I components that represent certain
secondary structure elements, some of which are 13C-labeled and the
others are not, undergo hydrogen-deuterium exchange (HX) with dis-
tinct rates, creating a dynamically transforming set of time-dependent
spectra (Fig. 3). In addition, both labeled andunlabeled amide oscillators
are involved in through-bond and through-space vibrational couplings
with 12C- or 13C-oscillators, which affects the frequencies and intensi-
ties of amide I components in a complex way (32–35).
During the first 90 min of HX, the high frequency wing of the amide
I band of membrane-bound, segmentally 13C-labeled hIBPLA2 shifts
toward lower frequencies by20 cm1 because of HX, whereas the low
frequency wing undergoes a more moderate downshift (Fig. 3A). The
second derivative spectra, which were used as a resolution enhance-
ment tool, reveal at least 10 components between 1690 and 1570 cm1
(Fig. 3B). A well defined amide I component at 1658 cm1 is readily
assigned to the unlabeled N-terminal -helix of hIBPLA2, whereas the
components at 1619 and 1609 cm1 are assigned to the unexchanged
and exchanged 13C-labeled helices of the protein, respectively (23,
32–38). The component at 1658 cm1 undergoes slowHX, because it is
only at 15 min following exposure to 2H2O that spectral downshift of
this component clearly manifests itself (Fig. 3B). On the other hand, the
signal assigned to the 13C-labeled helices 2 and 3 is split into compo-
nents at 1619 and 1609 cm1, already at 1min of exposure to 2H2O, and
undergoes little spectral change thereafter. As seen from the unproc-
essed amide I spectra (Fig. 3A), during the course of HX absorption
intensitymigrates from the high to the low frequency region, whichmay
partially compensate the decrease in the 1619 cm1 component during
HX. These spectral features thus may indicate an increased stability of
the N-terminal -helix of the hIBPLA2 compared with the two internal
helices.
The amide I bands of the membrane-bound segmentally 13C-labeled
chimeric N10IIA/IB PLA2 are different from those of the hIBPLA2 in
terms of both the spectral line shape and the dynamics. The high fre-
quencywing of the amide I band undergoes only an 8 cm1 downshift in
90 min, and despite this, the peak of the amide I band is located at
1608–1604 cm1 (Fig. 3C), which is 12 cm1 lower than the amide I
peak of the hIBPLA2 (Fig. 3A). These characteristics reflect the fact that
the component corresponding to the N-terminal helix of the chimeric
protein is still located at 1657 cm1, but the component corresponding
to the 13C-labeled helices 2 and 3 is shifted farther down to 1608–1604
cm1, as seen from the second derivative spectra of Fig. 3D. Moderate
spectral shifts for a protein in 2H2O indicates an overall more rigid
structure. The more rigid conformation of the chimeric PLA2 agrees
with the above conclusion deduced from CD data (Fig. 2B). Although
both unlabeled and 13C-labeled helices undergo gradualHX, resulting in
time-dependent diminution of corresponding signals in the second
derivative spectra (Fig. 3D), at 60–90 min following exposure to 2H2O
there still is a major component around 1604 cm1, whereas the com-
ponent around 1657 cm1 nearly vanishes. This may result from faster
HX of the N-terminal helix compared with the 13C-labeled helices,
which, in contrast to hIBPLA2, is indicative of more stable internal hel-
ices of the chimeric PLA2 compared with the N-terminal helix.
A possible interpretation of lower amide I frequency of the 13C-la-
beled -helices of the chimeric PLA2 compared with hIBPLA2might be
the formation of a double-stranded coiled-coil by the two internal hel-
ices of the chimeric PLA2 and sequestered, rigid helices in the hIBPLA2,
because two-stranded coiled-coils are characterized by significantly
lower amide I frequencies compared with standard -helices (39, 40).
TABLE ONE
Parameters characterizing membrane binding of PLA2s and N-terminal peptides
Values of pI and excess charge are calculated considering all cysteines are oxidized, with no account for the presence of Ca2 in PLA2 molecules because binding
experiments were conducted in the presence of 1 mM EGTA.
Molecule pI Excess charge at pH 7.4
20% POPG 40% POPG
KD Gb N KD Gb N
M kcal/mol M kcal/mol
hIBPLA2 9.29 2.174 6.04 9.49 36 1.44 10.34 36
N10hIB 11.17 2.998 2.50 10.01 9 0.60 10.86 9
hIIAPLA2 10.76 15.241 2.75 9.96 36 0.30 11.27 36
N10hIIA 11.0 2.065 5.72 9.52 9 2.50 10.01 9
N10IIA/IB 8.98 1.241 10.0 9.19 36 1.80 10.21 36
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However, this is not likely to be the case because the internal helices of
group I/II PLA2s are not long enough and lack heptad repeat features,
which facilitate helical coiled-coil formation (41). Amore substantiated
interpretation is based on consideration of the relative amide I intensity
and the spectral location of the 13C-helices. The ratios of apparent
extinction coefficient of 13C-labeled and unlabeled helices of both the
hIBPLA2 and the chimeric PLA2 were estimated as 13C/12C 
I13Cn12C/I12Cn13C, where I and n are the integrated amide I intensities
and the numbers of amino acid residues for corresponding helices,
respectively. The corrected, polarization-independent ATR-FTIR spec-
trawere used for such analysis, which indicated that 13C/12C  0.54 for
hIBPLA2 and 13C/12C  0.67 for the chimeric protein. Increased
absorptivity of the amide I mode of unlabeled versus 13C-labeled helices
was detected before for synthetic 32-mer peptides containing stretches
of three consecutive 13C-labeled residues (38). Our data indicate that
the amide I absorptivity of the 13C-labeled helices relative to the unla-
beled helix is higher in the chimeric PLA2 as compared with the hIB-
PLA2. On the other hand, the amide I peak of 13C-labeled -helices of
the chimeric protein occurs at lower frequencies compared with the
hIBPLA2. Because several studies have indicated that temperature-in-
duced destabilization of segmentally 13C-labeled -helical peptides was
accompanied with a decrease in intensity and an increase in the fre-
quency of both unlabeled and 13C-labeled segments (38, 42, 43), these
spectral features may be interpreted in terms of a more rigid structure
for the internal helices of the chimeric protein compared with the IB
PLA2. In support of this conclusion, it is worth mentioning that II-
helices, which are characterized bymuchweaker helical H-bonding and
are more flexible than standard I-helices (44), generate amide I modes
at 10–12 cm1 higher frequencies compared with regular -helices
(45–47).
The lower relative amide I intensity of the unlabeledN-terminal helix
of the N10IIA/IB PLA2 as compared with that of hIBPLA2 is consistent
with a more flexible N-terminal helix in the chimeric protein. Although
this latter inference would assume an upward spectral shift of the amide
I signal of theN-terminal helix in the chimeric PLA2 comparedwith that
of hIBPLA2, which has not been observed (both components occur at
1657–1658 cm1), still themost consistent conclusion from theCD and
ATR-FTIR experiments is that the overall structure of the chimeric
PLA2 ismore rigid than that of the hIBPLA2, but in the chimeric protein
the N-terminal helix is more flexible than the rest of the protein.
Membrane Binding of Group IB and IIA PLA2s, Their N-terminal
Peptides, and the Chimeric PLA2—Membrane binding is a crucial deter-
minant of PLA2 activity. Because in this work we consider the structural
and functional consequences of the substitution of the N-terminal helix
of hIBPLA2 by that of hIIAPLA2, we have determined and compared
membrane binding parameters of hIBPLA2, hIIAPLA2, theirN-terminal
peptides, and the chimeric N10IIA/IB PLA2. Fig. 4A shows representa-
tive fluorescence spectra indicating a gradual increase in the emission
intensity of FPE (2 mol % in membranes of large unilamellar vesicles)
with increasing concentration of hIBPLA2. The increments of fluores-
cence change at each protein concentration, F, were corrected by tak-
ing into account the decrease in fluorescence intensity due to sample
dilution (Fig. 4B) andwere used to construct the binding isotherms (Fig.
4C), as described under “Experimental Procedures.” The binding iso-
therms were described by Equations 3 and 4, and the dissociation con-
stants (KD) and the numbers of lipids per membrane-bound protein (N)
were evaluated from the best fit between the experimental and simu-
lated isotherms.
There is strong evidence that membrane binding of group I and II
PLA2s has a strong electrostatic component, resulting in poor binding to
FIGURE 3. Structural characterization of the
semisynthetic, segmentally 13C-labeled hIB-
PLA2 and the chimeric N10IIA/IB PLA2 by ATR-
FTIR spectroscopy. A, ATR-FTIR amide I bands of
the semisynthetic, segmentally 13C-labeled hIB-
PLA2 bound to a phospholipid bilayer membrane
supported on a germanium internal reflection
plate. The membrane was composed of POPC in
the lower leaflet (facing the plate) and POPC/
POPG (4:1, mol/mol) in the upper leaflet. Initially
the protein was dissolved in a buffer containing
100 mM NaCl, 1 mM NaN3, 1 mM EGTA, 50 mM Hepes
in H2O (pH 7.4) and was injected to the ATR cell
with the supported membrane. After binding of
the protein to the membrane, the cell was flushed
with a 2H2O-based buffer of the same composi-
tion, and spectra were recorded at parallel and
perpendicular orientations of the infrared light.
Presented here are the corrected and normalized
spectra. They were obtained as Acorrected  A 
0.8A, which are “polarization-independent” and
therefore reflect the true secondary structural fea-
tures of the protein, followed by normalization of
the total integrated area to 1 absorbance unit/cm.
The stacked spectra correspond to exposure of the
protein to 2H2O for 1, 3, 7.5, 26, 44, 66, and 90 min
(from top to bottom), which applies to all four pan-
els. B, the second derivative amide I spectra
derived from the spectra of A, accompanied with
13-point Savitzky-Golay smoothing. Here, as well
as in D, the wave numbers of prominent amide I
components are marked by vertically oriented
numbers. C, ATR-FTIR spectra of the semisynthetic,
segmentally 13C-labeled chimeric N10IIA/IB PLA2
bound to a supported membrane under identical
conditions as in A. D, the second derivative spectra
derived from spectra of C, accompanied with
13-point Savitzky-Golay smoothing.
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zwitterionic PC membranes and tight binding to anionic membranes
(48–50). For example, binding of human or snake group IIA PLA2s to
phospholipidmembranes could only be detected in the presence of15
mol % acidic lipid in membranes, such as DPPG or POPG (49, 50).
Correspondingly, the activity of hIIAPLA2 against phosphatidylcholine
vesicles is 1000–10,000-fold lower than against phosphatidylglycerol
vesicles (30, 49, 51). The dissociation constant of group IIA PLA2 for
zwitterionic membranes is in the millimolar range (48, 50, 52). Mam-
malian group IB PLA2s also exhibit poor binding to zwitterionic mem-
branes and low activity compared with membranes containing anionic
lipids (30). Involvement of a large electrostatic factor in membrane
binding of group I and II PLA2s is a physiologically intrinsic feature of
these enzymes. Our binding experiments indicated that not only group
IB and IIA PLA2s but also theirN-terminal peptides did not bind to pure
phosphatidylcholine membranes but did bind to membranes contain-
ing acidic lipid. Given all these circumstances, and the fact that most
biological membranes have surface charge corresponding to 20  5%
anionic lipids (53, 54), we usedmembranes containing 20% anionic lipid
in binding experiments. We also used membranes containing 40% ani-
onic lipid in order to determine the sensitivity of membrane binding of
all five molecules to the membrane surface charge (binding isotherms
are only shown for vesicles with 40% POPG in Fig. 4C). Parameters KD
andN for the binding of all five molecules to membranes containing 20
and 40mol % POPG are summarized in TABLEONE. The data indicate
that hIIAPLA2 and the N10hIB peptide exhibit tighter binding to mem-
branes containing 20 mol % POPG (KD  2.5–2.8 M) and 40 mol %
POPG (KD  0.3–0.6 M) compared with the other molecules. The
membrane binding affinity of hIIAPLA2 (in terms of KD) undergoes an
10-fold increase upon increasing the content of negative lipid inmem-
branes from 20 to 40 mol %. The sensitivity of membrane binding affin-
ity to the membrane negative surface charge decreases in the sequence:
hIIAPLA2 	 N10IIA/IB  hIBPLA2  N10hIB 	 N10hIIA. In order to
interpret these characteristics, the pI values and the excess charge of the
molecules, as shown in TABLE ONE, should be taken into account.
There is some, but inconsistent, correlation between the affinities for
anionic membranes and pI values of the molecules. The N10hIB pep-
tide, which has three cationic and no anionic residues (the C-terminal
carboxyl group is suggested to be compensated by the N-terminal
amino group), has the highest pI value and relatively high membrane
binding affinity but lower sensitivity to the membrane anionic charge
than the hIIAPLA2 and the chimeric protein. It is very likely that the
binding of proteins and peptides to anionic membranes is determined
not only by the pI values but, perhaps more importantly, by the actual
excess cationic charge of the molecule. For example, the hIIAPLA2 has
much higher excess positive charge than any of the molecules studied,
which results in strong binding to anionic membranes and high sensi-
tivity to the membrane surface charge. The chimeric protein, on the
other hand, has only 1.2 excess cationic charge at pH 7.4, resulting in
weaker membrane binding, especially at 20 mol % of acidic lipid in
membranes, and lower sensitivity to the membrane anionic charge.
The data of TABLE ONE indicate that membrane binding capabili-
ties of PLA2s are not additive in terms of such capabilities of their con-
stituent parts. The dissociation constants for the hIBPLA2 fragment
N10 that lacks the first 10 residues was determined previously to be 29
and 18.5 M for membranes containing 20 and 40 mol % POPG, which
correspond to the binding energies of 8.56 and 8.83 kcal/mol,
respectively (13). On the other hand, the respective membrane binding
energies of the N10hIIA peptide are 9.52 and 10 kcal/mol (TABLE
ONE). If themembrane binding energy of the chimericN10IIA/IB PLA2
was additively determined by those of the N10 fragment and the
N10hIIA peptide, then the chimeric protein would bind to membranes
with Gb  18 to 19 kcal/mol, whereas the experimentally meas-
ured values are only 9.2 to 10.2 kcal/mol. This is similar to earlier
findings that the membrane binding energy of the full-length hIBPLA2
was only 50% of the sum of binding energies of the N10 fragment
and the N10hIB peptide (13). Apparently, the functional role of the
N-terminal peptide of PLA2, which is absolutely required for the
enzyme activity (13), is not strengthening the membrane binding affin-
ity but rather is to facilitate a productive mode binding of the enzyme to
the membrane surface.
Positioning the Chimeric PLA2 at theMembrane Surface—Previously,
we have determined the precise positioning of hIBPLA2 on phospho-
lipidmembranes (18), andwe have shown that theN-terminal-helix is
a crucial determinant for the productivemodemembrane binding of the
enzyme (13). In order to understand the effect of the substitution of the
N-terminal -helix on the membrane binding mode of PLA2, here we
have studied the angular orientation of the membrane-bound chimeric
N10IIA/IB PLA2. Because our task was to achieve the structure of the
membrane-bound protein at atomic details, first we determined the
structure of the chimeric PLA2 by the internet-based server Swiss-
Model (24), using the structure of the porcine pancreatic PLA2 as a
template. The obtained structure revealed three -helices. The C-
atom coordinates of the three helices were used to determine the inter-
helical angles, 12  35.5o, 13  36.6o, and 23  6.2o, where ij is the
FIGURE 4. Quantitative characterization of binding of hIBPLA2, hIIAPLA2, their N-terminal peptides, and the chimeric N10IIA/IB PLA2 to phospholipid membranes. A,
dependence of fluorescence emission spectra of FPE, incorporated at 2 mol % in large unilamellar vesicles (100 nm in diameter) containing 58 mol % POPC and 40 mol % POPG, on
the concentration of hIBPLA2. The increasing darkness of lines corresponds to increasing concentrations of hIBPLA2, which are indicated in C. The buffer contained 10 mM Hepes, 1 mM
NaN3, 1 mM EGTA (pH 7.4). Excitation was at 490 nm. B, control experiments, in which buffer was added instead of PLA2 to FPE-containing vesicles in order to determine the effect of
sample dilution, which was used for correction of spectra in A. The increasing darkness of spectra corresponds to increasing sample dilution. Fluorescence spectra were measured using
a 0.4-cm optical path length quartz cuvette. C, membrane binding isotherms for hIBPLA2 (open circles), N10hIB peptide (closed circles), hIIAPLA2, (open squares), N10hIIA peptide
(closed squares), and the chimeric N10IIA/IB PLA2 (triangles). Lipid composition of vesicles and the buffer are as in A. The relative increase in peak fluorescence intensity of FPE,
F/Fmax, is plotted against protein concentration. The theoretical isotherms are simulated through Equations 3 and 4, using the binding parameters (KD and N) summarized in TABLE
ONE; all lines are continuous except for that describing the binding of the chimeric PLA2 (broken line).
Regulatory Role of PLA2 N-terminal Helix















angle between helices i and j. The fact that the helices 2 and 3 are nearly
parallel to each other allowed us to use a common order parameter for
these two helices in terms of their spatial orientation.
The next stepwas to determine the orientations of the unlabeled helix
1 and 13C-labeled helices 2 and 3 with respect to the membrane normal
for the membrane-bound chimeric PLA2, which was achieved by polar-
ized ATR-FTIR experiments. Fig. 5 shows the curve-fitted amide I spec-
tra of the membrane-bound protein at parallel and perpendicular
polarizations.
The intensities of polarized amide I components for the N-terminal
helix and for the 13C-labeled helices 2 and 3, which were spectrally
resolved because of an 50 cm1 downshift of the signal from the
13C-labeled helices, were used to evaluate the respective dichroic ratios
as R1  1.45  0.08 and R2,3  1.35  0.05, where the subscripts
indicate the corresponding -helices (shown are mean values and
standard deviations obtained from curve fitting of several polarized
amide I spectra). The mean values of dichroic ratios yield the order
parameters of S1  0.268 for the helix 1 and S2,3  0.392 for the
helices 2 and 3, with ranges of variation from 0.183 to 0.368 and
from 0.331 to 0.457, respectively. Interpretation of these uncertain-
ties in terms of angular orientation indicates that the amplitude of wob-
bling of the helices relative to the membrane normal does not exceed
10o, which is reasonable regarding the fluid nature of the membrane.
Thus, the ATR-FTIR measurements provide the helical orientations
with respect to the membrane with an acceptable degree of accuracy.
The order parameters were used to find the average tilt angles of the
respective helix axis relative to the membrane normal, cos
1  0.394
and cos
2,3  0.268. At this point, we had the orientations of all
helices in the protein coordinate system, p, and their orientations rel-
ative to the membrane normal (the z axis). This allowed expression of
cos
1 and cos
2,3 through the cosines of angles between helical axes
and the axes of the protein system pand the cosines of angles between
the z axis and the axes of the coordinate system p, cos(zx*), cos(zy*),
and cos(zz*), assuming these two coordinate systems are brought to a
common origin (see Ref. 18 for details). Combination of these with the
law of direction cosines: cos2(zx*)  cos2(zy*)  cos2(zz*)  1, allowed
determination of cos(zx*)  0.392, cos(zy*)  0.158, and cos(zz*) 
0.906. These three cosines determine the angular orientation of the
protein relative to the membrane normal.
In order to determine the structure of the membrane-bound protein,
i.e. the protein atom coordinates in the membrane coordinate system
m, the remaining six angles between the axes of the coordinate systems
m and p are also required. Because the membrane is only anisotropic
in the vertical dimension (the z axis) but is isotropic in the lateral dimen-
sion (the x and y axes), the protein has a rotational freedom about the z
axis but not the x or the y axes. Therefore, all azimuthal orientations of
the protein, i.e. all angles of rotation about the z axis, are equivalent. This
allowed us to select arbitrarily one of the six angles, e.g. cos(yx*) 0.456,
and use the laws of direction cosines to determine the remaining angles.
Thus, we obtained all nine angles between the axes of the coordinate
systems m and p: cos(zx*)  0.392, cos(zy*)  0.158, and
cos(zz*)  0.906, cos(yx*)  0.456, cos(yy*)  0.822, cos(yz*)  0.341,
cos(xx*)  0.799, cos(xy*)  0.547, cos(xz*)  0.250. These nine
cosines were used to transform the protein atom coordinates from the
protein system p to the membrane system m, assuming the two sys-
tems have a common origin.
The above operations only provide the angular orientation of the
protein relative to the membrane. The vertical location of the protein
relative to the membrane plane is still required to position the protein
on the membrane. This can be determined by membrane depth-de-
pendent fluorescence quenching of a protein-bound fluorophore by lip-
ids that contain quenchers at various positions of hydrocarbon chains.
We have determined previously the depth of insertion of hIBPLA2 into
POPC/POPGmembranes by this method (18). Although hIBPLA2 is an
appropriate protein for this purpose because it has a single tryptophan
at position 3, which is a part of the membrane binding face, this is not
the case with the chimeric N10IIA/IB PLA2 because this molecule is
devoid of tryptophans. Although other native fluorophores, such as
tyrosines, can also be used for quenching experiments, the abundance of
tyrosines in N10IIA/IB PLA2 prevents any meaningful interpretation of
the fluorescence quenching data in terms of the depth of membrane
insertion. Therefore, we used the information regarding membrane
insertion of hIBPLA2 in order to locate the chimeric N10IIA/IB PLA2
along the membrane normal. For the hIBPLA2, the geometric center of
the indole ring of Trp3 was located at 9 Å from the membrane center
(18). By assuming insertion of the chimeric N10IIA/IB PLA2 into the
membrane to a similar depth, and by taking into consideration the dif-
ference in size betweenTrp andVal, we positioned the side chain of Val3
of the chimeric protein at 10 Å from the membrane center. This was
done by adjusting the z coordinates of all atoms of the protein so the z
coordinate of the geometric center of Val3 was 10 Å, whereas the angu-
lar orientation of the protein with respect to the membrane was main-
tained as determined above. These procedures resulted in a model for
the structure of themembrane-bound chimericN10IIA/IB PLA2, which
is shown in Fig. 6A. In Fig. 6, A and B, three planes of atoms are intro-
duced that are perpendicular to the membrane normal and schemati-
cally identify the locations of terminal methyl carbons of the acyl chains
of glycerophospholipids (membrane center), the sn-1 carbonyl oxygens,
and the phosphorus atoms of lipid phosphate groups. The z coordinates
of these three planes are z  0, z  14.5 Å, and z  20 Å, respectively,
which is based on x-ray diffraction data on POPC bilayers (55).
The structure of the membrane-bound N10IIA/IB PLA2, which we
refer to as the quinary structure of a membrane protein (18), is consist-
ent with previously reported models of membrane anchoring of the
group I/II PLA2s (8, 56–58), with one important difference, i.e. the
depth of membrane insertion of the protein. Although penetration of
secretory PLA2s into membranes has not been reported by others, we
FIGURE 5. Determination of the angular orientation of the membrane-bound seg-
mentally 13C-labeled chimeric N10IIA/IB PLA2 by polarized ATR-FTIR spectroscopy.
The composition of the supported phospholipid bilayer and the method of sample prep-
aration are the same as in Fig. 3. The segmentally 13C-labeled N10IIA/IB PLA2 was dis-
solved in an H2O-based buffer of 100 mM NaCl, 1 mM NaN3, 1 mM EGTA, 50 mM Hepes (pH
7.4) and injected into the cell containing the supported membrane. After allowing the
protein to bind to the membrane (15 min), the cell was flushed with a similar buffer
prepared in 2H2O, and ATR-FTIR spectra were recorded at parallel (A) and perpendicular
(B) polarizations of the infrared light. Amide I components were generated by curve
fitting, using the second derivatives for resolution enhancement. Amide I components
corresponding to the N-terminal unlabeled -helix (dotted line) and the two 13C-labeled
-helices (dashed line) are located at 1657–1654 and at 1608 –1604 cm1, respectively.
The sum of all components is shown by dashed-dotted line, which nearly coincides with
the measured amide I contour.
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have documented insertion of hIBPLA2 into POPC/POPG membrane
to a depth of9Å from themembrane center (18), which is the basis for
positioning the chimeric PLA2 relative to the membrane surface as
shown in Fig. 6. The mode of membrane binding of the chimeric PLA2
resembles that of the hIBPLA2 (18). In both cases, the -helices 2 and 3
are tilted by 75° from the membrane normal toward the membrane
surface. The N-terminal -helix is oriented obliquely relative to the
membrane plane and is by 7° more tangential in the chimeric PLA2
than in hIBPLA2. As shown below, themembrane-boundN10hIIA pep-
tide also turned out to be oriented more laterally on the membrane
surface compared with the N10hIB peptide, implying that the orienta-
tion of the membrane-bound PLA2 is probably affected by the intrinsic
properties of the N-terminal helix. Membrane binding of the protein is
stabilized by hydrophobic, ionic, and H-bonding interactions. In Fig.
6A, the cationic side chains of Arg7, Lys10, and Lys116 are located at the
level of the hydrophobic/polar interface of the membrane and are very
likely to be involved in H-bonding with lipid carbonyl oxygens. Side
chains of other three lysines (residues 113, 121, and 122) are at the level
of lipid phosphate groups and are likely engaged in ionic contacts with
those groups. Side chains of three nonpolar residues, Val3, Phe19, and
Leu20, act as hydrophobic anchors for the PLA2-membrane interaction.
In this particular orientation, a hydrophobic spot of the protein, marked
by Leu64 and Leu65, is in the polar region of the ester carbonyl groups of
membrane lipids. Because the model of Fig. 6A presents an enzyme
bound to a membrane in the fluid phase rather than a rigid, immobile
structure, the protein is likely to have some degree of motional flexibil-
ity, including the angular orientation. The above estimates of the helical
order parameters, which are the basis for orientation determination,
indicated that within the accuracy of the measurements the orientation
of PLA2 can fluctuate within the limits of10o. Rotation of PLA2 by 10o
about an axis parallel to the x axis and passing through the center of the
protein molecule results in a structure presented in Fig. 6B. This seems
to be a viable structure because it is still close to the limits of experimen-
tal error and maintains the characteristic features of the structure
obtained using the average values of helical order parameters (Fig. 6A).
In this structure, the side chains of Leu64 and Leu65 are conveniently
embedded in the hydrocarbon chain region of the membrane, which
stabilizes the membrane binding of PLA2. This is in accord with earlier
indications that the loop containing these leucines is a part of interfacial
binding region of group IB PLA2s (9, 56) that is involved in conforma-
tional changes in the enzyme upon interfacial activation (8). On the
other hand, in this model Lys121 and Lys122, which form ionic bonds
with the lipid phosphate groups in the structure of Fig. 6A, are moved
farther away from the membrane surface. Also, the residues Lys113 and
Lys116 are located in a less energetically favorable manner than in
the model of Fig. 6A. These considerations lead to an inference that the
actualmembrane bindingmode of the protein is likely to be between the
two models presented in Fig. 6. It is also possible that PLA2 undergoes
transitions between distinct orientations during the catalytic process.
In order to determine whether the difference in the orientations of
membrane-bound hIBPLA2 and the chimeric N10IIA/IB PLA2, i.e. the
more horizontal orientation of the N-terminal helix of the chimeric
protein relative to themembrane plane, is dictated by the intrinsic prop-
erties of the N-terminal peptides of group IB and IIA PLA2s, we evalu-
ated the orientations of the peptides bound to supportedmembranes by
polarized ATR-FTIR. The amide I spectra of the N10hIIA peptide at
parallel and perpendicular orientations of the incident light were curve-
fitted using the frequencies of four components identified by second
derivatives (Fig. 7). The -helical components, which were centered
between 1653 and 1651 cm1, were used to evaluate the helical content
in themembrane-boundpeptide and its orientation. The helical content
was estimated as f  (A,  0.8A,/(A  0.8A)  46%, where A,
and A, are the areas of -helical components, whereas A and A are
the total amide I areas at the respective polarizations. This implies that
the membrane-bound N10hIIA peptide itself attains only partial -he-
licity, meaning that the helical conformation of the N terminus in the
full-length PLA2 is facilitated by interactionswith the rest of the protein.
Most interestingly, the N10hIB peptide was previously shown to con-
tain70% -helix when bound to supported POPC/POPGmembranes
(13). This suggests that the N-terminal domain of the hIBPLA2 has a
stronger helical propensity and forms more stable, or rigid, helices than
the N terminus of the hIIAPLA2, consistent with earlier findings dis-
cussed in the Introduction and with the data of this work. The -helical
dichroic ratio of the N10hIIA peptide was A,/A,  1.34, and the
order parameter was 0.41, corresponding to a tilt angle relative to
the membrane normal of 76o. For comparison, the tilt angle of the
FIGURE 6. Model for membrane-bound chimeric N10IIA/IB PLA2 obtained by homology modeling, polarized ATR-FTIR spectroscopy, and analytical geometry algorithms.
The structure in A was obtained by using the mean values of dichroic ratios of the unlabeled N-terminal -helix and of the two 13C-labeled -helices. The structure of PLA2 was
homology-modeled by Swiss-Model using porcine pancreatic PLA2 structure (Protein Data Bank entry 1P2P) as a template. The protein is presented in a ribbon format, with the
-helices 1–3 colored yellow, purple, and light blue, respectively. The side chains of amino acids directly involved in physical interactions with the membrane are shown in a stick
format; hydrophobic residues are shown in green and the cationic residues in blue. The catalytic His48 is shown in ball-and-stick format and colored rose. The three layers of nonprotein
atoms are introduced to schematically show membrane sections corresponding to the acyl chain terminal methyl carbons (gray), the sn-1 carbonyl oxygens (red), and the phosphorus
atoms (orange) of membrane glycerophospholipids. The z-coordinates of these layers are 0, 14.5, and 20 Å, respectively. The whole structure is turned about the z axis by 10o and
slightly (1o) about the y axis. Without these rotations, the plane of the picture would correspond to the yz plane. B, the protein has been rotated by 10o about an axis parallel to the
x axis, which results in immersion of Leu64 and Leu65 into the hydrophobic part of the membrane.
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N10hIB peptide was estimated to be 64o (13). These data suggest that
the N-terminal helix of the hIIAPLA2 binds to the membrane with a
more horizontal orientation than that of hIBPLA2. Given the larger tilt
angle of the N-terminal helix of the chimeric N10IIA/IB PLA2 com-
pared with that of hIBPLA2, these findings suggest that the mode of
membrane binding of PLA2 is affected by the intrinsic properties of the
N-terminal helix. Because the hydrophobic face of the amphipathic
N-terminal -helix forms a wall for the substrate-binding pocket of
PLA2 (6, 56), the orientation of the helix relative to themembrane plane
is likely to control the enzyme-substrate interaction step of the catalytic
reaction, again indicating a regulatory role of the N-terminal helix in
PLA2 function.
Determination of the membrane binding mode of a protein as
described in this work provides the structure of the proteins in which
the z coordinate of each atom is the distance from themembrane center.
The quinary structure of a membrane protein offers an unprecedented
opportunity to immediately determine the location of every single
amino acid residue, and each atom, relative to the structural moieties of
membrane lipids. In the models of Fig. 6, the entrance of the phospho-
lipid substrate into the catalytic pocket of the membrane-bound
enzyme is between theN-terminal helix and the highlightedHis48 and is
flanked by two loops from the left and the right. The z coordinates of the
imidazole nitrogens of the catalytic His48, which is located just slightly
above themembrane surface, are 22.6 Å. Considering that the sn-2 ester
groups of POPC and 1,2-dioleoyl-sn-glycero-3-phosphocholine are at
15.5 Å from themembrane center (55, 59), the phospholipidmolecule
has to travel only 7 Å in order to reach the catalytic center of the
enzyme, in contrast to the earlier conjectures assuming an 15 Å dis-
tance between the catalytic center of membrane-bound PLA2 and the
lipid cleavage site (6–8, 56, 58).
Conclusions—As a logical development of the previous findings that
the N-terminal -helix of PLA2 acts as a structural determinant for the
productive modemembrane binding and activation of the enzyme (13),
in this study we assess the effects of substitution of the N-terminal helix
of human group IB PLA2 by that of the group IIA PLA2 on membrane
binding properties and membrane-induced conformational changes in
PLA2. The chimeric PLA2 reveals conformational features that are dif-
ferent from those of hIBPLA2 and hIIAPLA2 and has severalfold lower
activity compared with both hIBPLA2 and hIIAPLA2. Although the
N-terminal helix of membrane-bound hIBPLA2 has a more rigid struc-
ture than the other helices, the structure of the chimeric PLA2 is more
rigid compared with both hIBPLA2 and hIIAPLA2, but the N-terminal
helix in the chimeric protein is flexible. The present data and earlier data
allow construction of amodel for themembrane-bound chimeric PLA2,
including the angular orientation and depth of membrane insertion.
The orientation of the N-terminal helix of the chimeric PLA2 is more
horizontal relative to the membrane surface compared with the hIB-
PLA2, which reflects the intrinsic membrane-binding properties of the
N10hIB and N10hIIA peptides. Membrane binding data indicate that
the binding affinity of N10IIA/IB PLA2 for anionicmembranes was 4–6
times weaker than that of hIIAPLA2 and was comparable with that of
hIBPLA2, implying that the N-terminal -helix is not as important in
the membrane binding strength of hIIAPLA2 as it is for hIBPLA2. In the
case of hIIAPLA2, which carries a tremendous excess cationic charge,
membrane binding is primarily driven by electrostatic interactions,
impeding binding to zwitterionicmembranes and facilitating binding to
anionicmembranes. In the case of hIBPLA2 that carries only amoderate
overall excess charge, theN-terminal helix is amajor determinant of the
membrane binding properties by virtue of three cationic charges and
Trp3. The N-terminal helix of group IB PLA2s seems to be a unique tool
that plays a critical role inmembrane binding and subsequent activation
of the enzymes. Somewhat surprisingly, the N-terminal helix of
hIIAPLA2, which has only two cationic residues and no Trp3, turns out
to support substantial activity and a productive membrane binding
modewhen substituted into hIBPLA2. These data provide evidence that
the N-terminal helix of PLA2s is an indispensable but substitutable
domain in terms of supporting the propermembrane bindingmode and
activity of the enzymes.
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